CXCL12 and ischemic cardiomyopathy: In addition, the enhancement of CXCR4 expression with HMGB1 treatment promotes the local migration to damaged tissue through the SDF-1/CXCR4 axis, which might be essential in DCM [23] as well as ischemic cardiomyopathy [24–26].